Drug Resistance Updates

Papers
(The H4-Index of Drug Resistance Updates is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2203
Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer194
Acquired non-thermal plasma resistance mediates a shift towards aerobic glycolysis and ferroptotic cell death in melanoma192
Editorial Board183
Editorial Board140
Editorial Board137
Editorial Board128
Modulating undruggable targets to overcome cancer therapy resistance120
LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein105
Circulating tumor cells with increasing aneuploidy predict inferior prognosis and therapeutic resistance in small cell lung cancer96
Intersecting pathways: The role of hybrid E/M cells and circulating tumor cells in cancer metastasis and drug resistance82
CircPDIA3/miR-449a/XBP1 feedback loop curbs pyroptosis by inhibiting palmitoylation of the GSDME-C domain to induce chemoresistance of colorectal cancer79
Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins74
Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases74
The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells69
CEA-induced PI3K/AKT pathway activation through the binding of CEA to KRT1 contributes to oxaliplatin resistance in gastric cancer68
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming67
CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosis67
The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity66
GATA3 mediates doxorubicin resistance by inhibiting CYB5R2-catalyzed iron reduction in breast cancer cells65
Silver-dendrimer nanocomposite as emerging therapeutics in anti-bacteria and beyond59
Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma56
A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma55
Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance54
Prophylactic use of antibiotics – A strategy with unforeseen risks?53
Plasmid-borne tigecycline resistance gene tet(X4) in Salmonella enterica and Escherichia coli isolates from a pediatric patient with diarrhea53
Widespread loss-of-function mutations implicating preexisting resistance to new or repurposed anti-tuberculosis drugs52
Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor52
Surface chemistry engineered selenium nanoparticles as bactericidal and immuno-modulating dual-functional agents for combating methicillin-resistant Staphylococcus aureus Infection50
A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis47
Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment44
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance44
Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment44
ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance43
Molecular Modeling Strategies of Cancer Multidrug Resistance43
Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics40
MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma37
Antibiotic failure: Beyond antimicrobial resistance37
0.053831100463867